Search research articles
Contact Us
Filters
Showing results (51-60 of 107) with videos related to
Page
of 11
Sort By:
Reproductive Biomedicine Online
|
January 29, 2013
Fertility in cancer patients after cryopreservation of one ovary
K T Schmidt, A Nyboe Andersen, T Greve, et al.
Human Reproduction (Oxford, England)
|
January 14, 2014
Large baby syndrome in singletons born after frozen embryo transfer (FET): is it due to maternal factors or the cryotechnique?
A Pinborg, A A Henningsen, A Loft, et al.
Human Reproduction (Oxford, England)
|
June 22, 1999
Delivery rates after in-vitro fertilization following bilateral salpingectomy due to hydrosalpinges: a case control study
H E Bredkjaer, S Ziebe, B Hamid, et al.
Human Reproduction (Oxford, England)
|
May 20, 2008
Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial
K Lossl, C Yding Andersen, A Loft, et al.
Ugeskrift for Laeger
|
August 30, 2000
[Infertility in ethnic groups. Etiology and treatment]
B S Hassan Hamid, S Ziebe, A Loft, et al.
Human Reproduction (Oxford, England)
|
July 14, 2012
A randomized controlled dose-response pilot study of addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization
L L Thuesen, A Loft, A N Egeberg, et al.
Human Reproduction (Oxford, England)
|
June 21, 2006
Androgen priming using aromatase inhibitor and hCG during early-follicular-phase GnRH antagonist down-regulation in modified antagonist protocols
K Lossl, A N Andersen, A Loft, et al.
Human Reproduction (Oxford, England)
|
October 31, 2003
A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment
B Popovic-Todorovic, A Loft, H Ejdrup Bredkjaeer, et al.
Human Reproduction (Oxford, England)
|
October 21, 1999
A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon((R))) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP((R))) in a fixed-dose regimen in women undergoing ovarian stimulation
E H Hoomans, A N Andersen, A Loft, et al.
Human Reproduction (Oxford, England)
|
May 5, 2017
The long-term prognosis for live birth in couples initiating fertility treatments
S S Malchau, A A Henningsen, A Loft, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 107) with videos related to
Sort By:
Page
of 11
Reproductive Biomedicine Online
|
January 29, 2013
Fertility in cancer patients after cryopreservation of one ovary
K T Schmidt, A Nyboe Andersen, T Greve, et al.
Human Reproduction (Oxford, England)
|
January 14, 2014
Large baby syndrome in singletons born after frozen embryo transfer (FET): is it due to maternal factors or the cryotechnique?
A Pinborg, A A Henningsen, A Loft, et al.
Human Reproduction (Oxford, England)
|
June 22, 1999
Delivery rates after in-vitro fertilization following bilateral salpingectomy due to hydrosalpinges: a case control study
H E Bredkjaer, S Ziebe, B Hamid, et al.
Human Reproduction (Oxford, England)
|
May 20, 2008
Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial
K Lossl, C Yding Andersen, A Loft, et al.
Ugeskrift for Laeger
|
August 30, 2000
[Infertility in ethnic groups. Etiology and treatment]
B S Hassan Hamid, S Ziebe, A Loft, et al.
Human Reproduction (Oxford, England)
|
July 14, 2012
A randomized controlled dose-response pilot study of addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization
L L Thuesen, A Loft, A N Egeberg, et al.
Human Reproduction (Oxford, England)
|
June 21, 2006
Androgen priming using aromatase inhibitor and hCG during early-follicular-phase GnRH antagonist down-regulation in modified antagonist protocols
K Lossl, A N Andersen, A Loft, et al.
Human Reproduction (Oxford, England)
|
October 31, 2003
A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment
B Popovic-Todorovic, A Loft, H Ejdrup Bredkjaeer, et al.
Human Reproduction (Oxford, England)
|
October 21, 1999
A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon((R))) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP((R))) in a fixed-dose regimen in women undergoing ovarian stimulation
E H Hoomans, A N Andersen, A Loft, et al.
Human Reproduction (Oxford, England)
|
May 5, 2017
The long-term prognosis for live birth in couples initiating fertility treatments
S S Malchau, A A Henningsen, A Loft, et al.
Page
of 11